Skip to Main Content
Back to News

Insiders, hedge funds, and politicians trading Abbott Laboratories stock (NYSE:ABT) in Q1 2024

CTO

$ABT earnings are coming up. Here is a look at recent trades of $ABT by people who might have an edge.

Congress
Members of Congress have disclosed trades of $ABT stock 3 times in the last quarter. Of those trades, 0 have been purchases and 3 have been sales.

Here’s a breakdown of recent trading of $ABT stock by members of Congress:
- Representative Kathy E. Manning has traded $ABT 2 times. They made 0 purchases and 2 sales worth up to $30,000 on 01/23.
- Senator Carper, Thomas R. sold up to $15,000 on 01/17.

Company Insiders
No recent insider trades of $ABT on record.

Institutions
Here’s a breakdown of some of the largest recent moves of $ABT stock:
- CAPITAL RESEARCH GLOBAL INVESTORS bought an estimated $819,699,746 of $ABT stock
- JANUS HENDERSON GROUP PLC bought an estimated $415,051,766 of $ABT stock
- BOSTON PARTNERS bought an estimated $407,565,687 of $ABT stock
- PUTNAM INVESTMENTS LLC sold an estimated $404,301,383 of $ABT stock
- JPMORGAN CHASE & CO sold an estimated $376,479,117 of $ABT stock

About the Author

Christopher Kardatzke is the CTO and cofounder of Quiver Quantitative. Prior to starting Quiver, Christopher worked in software development for Epic Systems, and was the founder of the UW-Madison Quantitative Finance Club.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles